New research collaboration between Uppsala Monitoring Centre and CauseHealth

IMG_3676
UMC Director Marie Lindquist with Rani Anjum and Elena Rocca. Photo: UMC

At 1 October 2018, a new collaborative research project started at NMBU that brings CauseHealth into its second phase; of CauseHealth pharmacovigilance. Continue reading “New research collaboration between Uppsala Monitoring Centre and CauseHealth”

Living with complexity and big data. Causal dispositionalim enters pharmacovigilance

Ralph Edwards on dispositionalism in pharmacovigilance

We have seen a lot of interest in the CauseHealth approach and issues during these last years, especially among clinicians who see a need for a more person centered healthcare. Can this be useful also outside the clinic? Yes, according to senior medical advisor at the WHO Uppsala Monitoring Center for Drug Safety, Ralph Edwards. In a recent perspectives article in the UMC report, he argues that dispositionalism can be useful for dealing with complexity, individual variation and the patient’s unique context. Continue reading “Living with complexity and big data. Causal dispositionalim enters pharmacovigilance”

CauseHealth goes to Evidence Live

Evidence-live-2-date

Evidence Live is an annual conference, jointly hosted by the Centre for Evidence-Based Medicine, University of Oxford and The BMJ. This year, CauseHealth was represented in two of the sessions, by Elena Rocca and Rani Lill Anjum. Continue reading “CauseHealth goes to Evidence Live”

Evidence synthesis in pharmacology

By Elena Rocca

Pharmacology is a complex science that aims to balance harm and benefit of treatments for the individual patient.¬†How should different types of evidence be synthesised in order to optimize this task? Should evidence from randomized trials be prioritized over other evidence, following the EBM model? If not, how can different types of evidence be amalgamated in an alternative way? Continue reading “Evidence synthesis in pharmacology”